ES2005057A4 - Lisados bacterianos antigenicos, un proceso para la preparacion de estos y compuestos farmaceuticos que los contienen. - Google Patents

Lisados bacterianos antigenicos, un proceso para la preparacion de estos y compuestos farmaceuticos que los contienen.

Info

Publication number
ES2005057A4
ES2005057A4 ES87116752T ES87116752T ES2005057A4 ES 2005057 A4 ES2005057 A4 ES 2005057A4 ES 87116752 T ES87116752 T ES 87116752T ES 87116752 T ES87116752 T ES 87116752T ES 2005057 A4 ES2005057 A4 ES 2005057A4
Authority
ES
Spain
Prior art keywords
lisates
contain
preparation
pharmaceutical compounds
antigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES87116752T
Other languages
English (en)
Inventor
Giuseppe Monti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Sieroterapico Milanese Xs Belfantix
Original Assignee
St Sieroterapico Milanese Xs Belfantix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Sieroterapico Milanese Xs Belfantix filed Critical St Sieroterapico Milanese Xs Belfantix
Publication of ES2005057A4 publication Critical patent/ES2005057A4/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE DESCRIBE UN LISADO BACTERIANO ANTIGENICO PREPARADO MEDIANTE EXPOSICION DE LAS CEPAS BACTERIANAS A UNA LISIS SELECTIVA, PARTICULARMENTE STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS PYOGENES, STREPTOCOCCUS VIRIDANS, DIPLOCOCCUS PNEUMONIAE, KLEBSIELLA PNEUMONIAE, KLEBSIELLA OZAENAE, HAEMOPHILUS INFLUENZAE TIPO B, Y NEISSERIA CATARRALIS. LOS LISADOS OBTENIDOS SE USAN COMO VACUNAS, PARA SER ADMINISTRADAS POR VIA ORAL EN EL TRATAMIENTO DE LAS ENFERMEDADES INFECCIOSAS DEL TRACTO RESPIRATORIO, PARTICULARMENTE EN LA PREVENCION DE LAS RECIDIVAS Y LAS TRANSFORMACIONES EN CONDICIONES CRONICAS.
ES87116752T 1986-11-21 1987-11-13 Lisados bacterianos antigenicos, un proceso para la preparacion de estos y compuestos farmaceuticos que los contienen. Pending ES2005057A4 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48677/86A IT1199301B (it) 1986-11-21 1986-11-21 Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono

Publications (1)

Publication Number Publication Date
ES2005057A4 true ES2005057A4 (es) 1989-03-01

Family

ID=11267997

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87116752T Pending ES2005057A4 (es) 1986-11-21 1987-11-13 Lisados bacterianos antigenicos, un proceso para la preparacion de estos y compuestos farmaceuticos que los contienen.

Country Status (7)

Country Link
EP (1) EP0269928A3 (es)
JP (1) JPS63233929A (es)
BE (1) BE905911A (es)
DE (1) DE269928T1 (es)
ES (1) ES2005057A4 (es)
GR (1) GR880300141T1 (es)
IT (1) IT1199301B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100509817B1 (ko) * 1997-06-27 2005-12-16 씨제이 주식회사 비브리오불니피쿠스의감염예방을위한경구용백신
EP1641488B1 (en) 2003-06-23 2011-03-30 Biotech Tools S.A. Epitope composition for enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
WO2005027829A2 (en) * 2003-09-03 2005-03-31 Intralytix, Inc. Method for vaccination of poultry by bacteriophage lysate
PL2114421T3 (pl) 2007-03-05 2018-07-31 Om Pharma Ekstrakt bakteryjny do stosowania względem zaburzeń oddechowych i sposób jego wytwarzania

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792256C3 (de) * 1968-08-10 1979-07-05 Kali-Chemie Pharma Gmbh, 3000 Hannover Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen
US3929994A (en) * 1969-05-20 1975-12-30 Roussel Uclaf Anti-inflammatory glycoprotein compositions and method of use
BE795417A (fr) * 1972-02-15 1973-08-14 Roussel Uclaf Nouveaux composes d'origine-bacterienne et procede d'obtention
CA1262442A (en) * 1984-03-09 1989-10-24 Yasuo Kawai Anticariogenic or antiperiodontitic agent
CH664497A5 (de) * 1984-08-31 1988-03-15 Solco Basel Ag Vakzine zur behandlung der harnwegsinfektionen.

Also Published As

Publication number Publication date
JPS63233929A (ja) 1988-09-29
DE269928T1 (de) 1988-11-03
EP0269928A3 (en) 1990-02-07
GR880300141T1 (en) 1988-12-16
IT8648677A0 (it) 1986-11-21
IT1199301B (it) 1988-12-30
BE905911A (fr) 1987-04-01
EP0269928A2 (en) 1988-06-08

Similar Documents

Publication Publication Date Title
Tindall et al. Pasteurella multocida infections following animal injuries, especially cat bites
Dabard et al. Experimental reproduction of neonatal diarrhea in young gnotobiotic hares simultaneously associated with Clostridium difficile and other Clostridium strains
ES2005057A4 (es) Lisados bacterianos antigenicos, un proceso para la preparacion de estos y compuestos farmaceuticos que los contienen.
Duckett Ernest Duchesne and the concept of fungal antibiotic therapy
JPH0463861B2 (es)
Haq et al. Comparative efficacy of Norfloxacin, Clarithromycin and Cefpodoxime against experimentally induced colibacillosis in pigeons
FR2426470A1 (fr) Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires
Barnum A herd outbreak of mastitis caused by Pasteurella Multocida
ATE1146T1 (de) 3-chlor-6-hydroxy-5-methyl-benzoesaeure-derivate die entsprechenden pharmazeutischen zusammensetzungen, das wachstum bestimmter tiere stimulierende zusammensetzungen und deren herstellung.
Aleshkin et al. Bacteriophages in therapy and prevention of acute intestinal infections in children
Bornstein et al. Selective Action of Sulfanilyl-Guanidine on Different Salmonella Types and Its Practical Importance.
Smith Symposium on diseases of cats—III. Some pathogenic bacteria of cats with special reference to their public health significance
ES442505A1 (es) Procedimiento de preparacion de la 4-0-n2',6'-diamino-2',3',6' - tridesoxi-alfa, d-ribohexopiranosiln6-0 - n3" - metila-mino-3",4",6"tridesoxi alfa,d-xilohexopiranosiln2-desoxies- treptamina.
Parker et al. Salmonella enteritidis: experimental transmission by the Rocky Mountain wood tick Dermacentor andersoni Stiles
Van Heerden, J. and Van Heerden Attempted treatment of canine ehrllchiosis with imidocarb dipropionate
Platt Treatment of pneumonia in children with a single dose of sulfapyridine
FR2307542A1 (fr) Nouvelle preparation immunostimulante
Marcus et al. Treatment of Spontaneous Canine Distemper with Sulfanilamide.
RU2813777C1 (ru) Способ лечения пастереллеза крупного рогатого скота
Bentley et al. Efficacy of sulbactam, a b-lactamase inhibitor, combined with ampicillin in the therapy of ampicillin-resistant pneumonic pasteurellosis in feedlot calves
ES2075221T3 (es) Proceso para la preparacion de una composicion farmaceutica para el tratamiento de las enfermedades de la piel, especialmente las dermatitis piogenas y atopicas.
Michael Long-term cotrimoxazole improves outcomes in children with HIV/AIDS
Pilot et al. Human carriers of Streptococcus epidemicus
Florman et al. Nonspecific enhancers of resistance in man
JP2023134853A5 (es)